Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Study - Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients

NCT02658188 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT02658188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02658188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Study - Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients
Lead sponsor
Astellas Pharma Inc
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2007
Completion date
April 30, 2009
Enrollment
182 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

restless legs syndrome